Citi resumed coverage of Medtronic (MDT) with a Buy rating and $117 price target after a period of the rating being suspended, while also re-establishing the stock as a Top Pick. With several headwinds receding and many larger addressable market products “just getting started,” Medtronic “seems to have turned a corner,” the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT: